Gemmer Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-132
| Closed | -$92K | – | 896 |
|
|
2022
Q1 | $92K | Hold |
132
| – | – | 0.01% | 176 |
|
|
2021
Q4 | $83K | Hold |
132
| – | – | 0.01% | 194 |
|
|
2021
Q3 | $80K | Sell |
132
-8
| -6% | -$4.97K | 0.01% | 181 |
|
|
2021
Q2 | $78K | Buy |
140
+1
| +0.7% | +$507 | 0.01% | 206 |
|
|
2021
Q1 | $66K | Hold |
139
| – | – | 0.01% | 212 |
|
|
2020
Q4 | $67K | Hold |
139
| – | – | 0.01% | 200 |
|
|
2020
Q3 | $78K | Hold |
139
| – | – | 0.01% | 146 |
|
|
2020
Q2 | $87K | Buy |
139
+8
| +6% | +$4.54K | 0.02% | 139 |
|
|
2020
Q1 | $64K | Hold |
131
| – | – | 0.02% | 153 |
|
|
2019
Q4 | $49K | Hold |
131
| – | – | 0.01% | 196 |
|
|
2019
Q3 | $36K | Buy |
131
+4
| +3% | +$1.18K | 0.01% | 248 |
|
|
2019
Q2 | $40K | Sell |
127
-23
| -15% | -$7.66K | 0.01% | 218 |
|
|
2019
Q1 | $62K | Hold |
150
| – | – | 0.02% | 166 |
|
|
2018
Q4 | $56K | Hold |
150
| – | – | 0.02% | 160 |
|
|
2018
Q3 | $61K | Hold |
150
| – | – | 0.02% | 160 |
|
|
2018
Q2 | $52K | Hold |
150
| – | – | 0.02% | 179 |
|
|
2018
Q1 | $52K | Sell |
150
-30
| -17% | -$10.4K | 0.02% | 180 |
|
|
2017
Q4 | $68K | Buy |
180
+30
| +20% | +$12.2K | 0.02% | 161 |
|
|
2017
Q3 | $67K | Sell |
150
-15
| -9% | -$7.14K | 0.03% | 152 |
|
|
2017
Q2 | $81K | Hold |
165
| – | – | 0.03% | 131 |
|
|
2017
Q1 | $64K | Hold |
165
| – | – | 0.03% | 151 |
|
|
2016
Q4 | $61K | Hold |
165
| – | – | 0.03% | 142 |
|
|
2016
Q3 | $66K | Hold |
165
| – | – | 0.03% | 131 |
|
|
2016
Q2 | $58K | Hold |
165
| – | – | 0.03% | 142 |
|
|
2016
Q1 | $59K | Hold |
165
| – | – | 0.03% | 146 |
|
|
2015
Q4 | $90K | Hold |
165
| – | – | 0.05% | 104 |
|
|
2015
Q3 | $77K | Hold |
165
| – | – | 0.05% | 119 |
|
|
2015
Q2 | $84K | Hold |
165
| – | – | 0.05% | 120 |
|
|
2015
Q1 | $74K | Hold |
165
| – | – | 0.04% | 132 |
|
|
2014
Q4 | $68K | Sell |
165
-7
| -4% | -$2.75K | 0.05% | 137 |
|
|
2014
Q3 | $62K | Hold |
172
| – | – | 0.04% | 149 |
|
|
2014
Q2 | $49K | Hold |
172
| – | – | 0.03% | 169 |
|
|
2014
Q1 | $52K | Buy |
+172
| New | +$53K | 0.04% | 164 |
|
Other funds holding REGN
Gemmer Asset Management's REGN Position: Q2 2022 in Review
Gemmer Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 132 shares — an estimated $92K sold.
Gemmer Asset Management first reported a position in REGN in Q1 2014 and held it in 33 quarters. The position peaked at $92K in Q1 2022. 1,064 funds tracked by Wall St. Rank hold REGN as of Q2 2022.
- Gemmer Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
- Gemmer Asset Management sold 132 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $92K.
- Gemmer Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 33 quarters.
- Gemmer Asset Management's Regeneron Pharmaceuticals position peaked at $92K in Q1 2022.
- 1,064 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.
Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.